Search research articles
Contact Us
Filters
Showing results (141-150 of 185) with videos related to
Page
of 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958)
M E R O'Brien, T Splinter, E F Smit, et al.
Cancer Chemotherapy and Pharmacology
|
March 9, 2006
Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer
J R Kroep, E F Smit, G Giaccone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2001
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients
M Klein, M J Taphoorn, J J Heimans, et al.
British Journal of Cancer
|
December 4, 2008
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
M I Galleges Ruiz, K Floor, S M Steinberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation
S Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 2012
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients
D E Ediebah, C Coens, J T Maringwa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2010
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity
E C J Phernambucq, F O B Spoelstra, W F A R Verbakel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2011
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study
B Biesma, A N M Wymenga, A Vincent, et al.
Immuno-Oncology Technology
|
August 26, 2024
Integrated noninvasive diagnostics for prediction of survival in immunotherapy
M Yeghaian, Z Bodalal, T M Tareco Bucho, et al.
British Journal of Cancer
|
April 19, 2014
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial
D E Ediebah, C Coens, E Zikos, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 185) with videos related to
Sort By:
Page
of 19
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958)
M E R O'Brien, T Splinter, E F Smit, et al.
Cancer Chemotherapy and Pharmacology
|
March 9, 2006
Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer
J R Kroep, E F Smit, G Giaccone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2001
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients
M Klein, M J Taphoorn, J J Heimans, et al.
British Journal of Cancer
|
December 4, 2008
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
M I Galleges Ruiz, K Floor, S M Steinberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation
S Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 2012
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients
D E Ediebah, C Coens, J T Maringwa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2010
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity
E C J Phernambucq, F O B Spoelstra, W F A R Verbakel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2011
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study
B Biesma, A N M Wymenga, A Vincent, et al.
Immuno-Oncology Technology
|
August 26, 2024
Integrated noninvasive diagnostics for prediction of survival in immunotherapy
M Yeghaian, Z Bodalal, T M Tareco Bucho, et al.
British Journal of Cancer
|
April 19, 2014
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial
D E Ediebah, C Coens, E Zikos, et al.
Page
of 19